We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA's Financial Disclosure Regulations: careful compliance in a changing landscape - Part II

01 March 2011

Medical Device Alert

The FDA financial disclosure regulations are designed to help uncover potential investigator bias that may arise due to financial ties between the investigator and the clinical trial sponsor.



Read "FDA's Financial Disclosure Regulations: careful compliance in a changing landscape - Part II"
Loading data